General information about company |
|
|---|---|
| Scrip code | 000000 |
| NSE Symbol | MONOPHARMA |
| MSEI Symbol | NOTLISTED |
| ISIN | INE0OIP01012 |
| Name of Company | MONO PHARMACARE LIMITED |
| Type of company | SME |
| Class of security | Equity |
| Date of start of financial year | 01-Apr-2024 |
| Date of end of financial year | 31-Mar-2025 |
| Date of board meeting when results were approved | 30-May-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 27-May-2025 |
| Description of presentation currency | INR (in Actuals) |
| Reporting Type | Half Yearly |
| Reporting Quarter | Yearly |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Segment Reporting | Single segment |
| Description of single segment | Single segment |
| Start date and time of board meeting | 30-May-2025 16:00:00 |
| End date and time of board meeting | 30-May-2025 20:30:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
Financial Results — Other than Bank |
|||
|---|---|---|---|
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-Oct-2024 | 01-Apr-2024 |
| B | Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column. | ||
| 1 | Revenue From Operations | ||
| Revenue from operations | 811822000 | 1683449000 | |
| Other income | 9361000 | 9788000 | |
| Total Income | 821183000 | 1693237000 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0 | 0 |
| (b) | Purchases of stock-in-trade | 806031000 | 1654113000 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | -76430000 | -130935000 |
| (d) | Employee benefit expense | 20847000 | 37867000 |
| (e) | Finance costs | 24625000 | 40255000 |
| (f) | Depreciation and amortisation expense | 644000 | 1287000 |
| (g) | Other Expenses | ||
| 1 | Other expenses | 32358000 | 46022000 |
| Total other expenses | 32358000 | 46022000 | |
| Total expenses | 808075000 | 1648609000 | |
| 3 | Profit before exceptional and extraordinary items and tax | 13108000 | 44628000 |
| 4 | Exceptional items | 0 | 0 |
| 5 | Profit before extraordinary items and tax | 13108000 | 44628000 |
| 6 | Extraordinary items | 0 | 0 |
| 7 | Profit before tax | 13108000 | 44628000 |
| 8 | Tax Expense | ||
| Current tax | 5305000 | 13900000 | |
| Deferred tax | 408000 | -330000 | |
| Total tax expenses | 5713000 | 13570000 | |
| 9 | Net Profit Loss for the period from continuing operations | 7395000 | 31058000 |
| 10 | Profit (loss) from discontinuing operations before tax | 0 | 0 |
| 11 | Tax expense of discontinuing operations | 0 | 0 |
| 12 | Net profit (loss) from discontinuing operation after tax | 0 | 0 |
| 13 | Profit (loss) for period before minority interest | 7395000 | 31058000 |
| 14 | Share of profit (loss) of associates | 0 | 0 |
| 15 | Profit (loss) of minority interest | -82000 | -157000 |
| 16 | Net profit (Loss) for the period | 7313000 | 30901000 |
| 17 | Details of equity share capital | ||
| Paid-up equity share capital | 176686000 | 176686000 | |
| Face value of equity share capital | 10 | 10 | |
| 18 | Reserves excluding revaluation reserve | 0 | |
| 19 | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 0.45 | 1.75 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 0.45 | 1.75 | |
| 20 | Debt equity ratio | ||
| 21 | Debt service coverage ratio | ||
| 22 | Interest service coverage ratio | ||
| 23 | Disclosure of notes on financial results | ||
Remarks |
||
|---|---|---|
| 20 | Debt equity ratio | |
| 21 | Debt service coverage ratio | |
| 22 | Interest service coverage ratio | |
Cash flow statement — indirect |
||||
|---|---|---|---|---|
| A | Date of start of reporting period | 01-Apr-2024 | ||
| B | Date of end of reporting period | 31-Mar-2025 | ||
| C | Whether results are audited or unaudited | Audited | ||
| D | Nature of report standalone or consolidated | Consolidated | ||
| 1 | Statement of cash flows | |||
| Cash flows from used in operating activities | ||||
| Profit before extraordinary items and tax | 44628000 | |||
| 2 | Adjustments for reconcile profit (loss) | |||
| Adjustments to profit (loss) | ||||
| Adjustments for finance costs | 40255000 | |||
| Adjustments for depreciation and amortisation expense | 1287000 | |||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0 | |||
| Adjustments for unrealised foreign exchange losses gains | 0 | |||
| Adjustments for dividend income | 0 | |||
| Adjustments for share-based payments | 0 | |||
| Other adjustments for which cash effects are investing or financing cash flow | 0 | |||
| Other adjustments to reconcile profit (loss) | 0 | |||
| Other adjustments for non-cash items | 0 | |||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0 | |||
| Total adjustments to profit (loss) | 41542000 | |||
| 3 | Adjustments for working capital | |||
| Adjustments for decrease (increase) in inventories | -130935000 | |||
| Adjustments for decrease (increase) in trade receivables | -102972000 | |||
| Adjustments for decrease (increase) in other current assets | 3263000 | |||
| Adjustments for increase (decrease) in trade payables | 91132000 | |||
| Adjustments for increase (decrease) in other current liabilities | 36286000 | |||
| Adjustments for provisions | -12072000 | |||
| Total adjustments for working capital | -115298000 | |||
| Total adjustments for reconcile profit (loss) | -73756000 | |||
| Net cash flows from (used in) operations | -29128000 | |||
| Dividends received | 0 | |||
| Interest paid | 0 | |||
| Interest received | 0 | |||
| Income taxes paid (refund) | 13900000 | |||
| Other inflows (outflows) of cash | 0 | |||
| Net cash flows from (used in) operating activities before extraordinary items | -43028000 | |||
| Proceeds from extraordinary items | 0 | |||
| Payment for extraordinary items | 0 | |||
| Net cash flows from (used in) operating activities | -43028000 | |||
| 4 | Cash flows from used in investing activities | |||
| Cash flows from losing control of subsidiaries or other businesses | 0 | |||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0 | |||
| Other cash receipts from sales of equity or debt instruments of other entities | 0 | |||
| Other cash payments to acquire equity or debt instruments of other entities | 0 | |||
| Other cash receipts from sales of interests in joint ventures | 0 | |||
| Other cash payments to acquire interests in joint ventures | 0 | |||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0 | |||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0 | |||
| Proceeds from sales of property plant and equipment | 0 | |||
| Purchase of property plant and equipment | 2263000 | |||
| Proceeds from sales of intangible assets | 0 | |||
| Purchase of intangible assets | 0 | |||
| Cash advances and loans made to other parties | 0 | |||
| Cash receipts from repayment of advances and loans made to other parties | 0 | |||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0 | |||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0 | |||
| Dividends received | 0 | |||
| Interest received | 0 | |||
| Income taxes paid (refund) | 0 | |||
| Other inflows (outflows) of cash | 0 | |||
| Proceeds from government grants | 0 | |||
| Net cash flows from (used in) investing activities before extraordinary items | -2263000 | |||
| Proceeds from extraordinary items | 0 | |||
| Payment for extraordinary items | 0 | |||
| Net cash flows from (used in) investing activities | -2263000 | |||
| Cash flows from used in financing activities | ||||
| Proceeds from issuing shares | 0 | |||
| Proceeds from issuing other equity instruments | 0 | |||
| Proceeds from issuing debentures notes bonds etc | 0 | |||
| Proceeds from borrowings | 88486000 | |||
| Repayments of borrowings | 0 | |||
| Dividends paid | 0 | |||
| Interest paid | 0 | |||
| Income taxes paid (refund) | 0 | |||
| Other inflows (outflows) of cash | -39846000 | |||
| Net cash flows from (used in) financing activities before extraordinary items | 48640000 | |||
| Proceeds from extraordinary items | 0 | |||
| Payment for extraordinary items | 0 | |||
| Net cash flows from (used in) financing activities | 48640000 | |||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 3349000 | |||
| 6 | Effect of exchange rate changes on cash and cash equivalents | |||
| Effect of exchange rate changes on cash and cash equivalents | 0 | |||
| Net increase (decrease) in cash and cash equivalents | 3349000 | |||
| Cash and cash equivalents cash flow statement at beginning of period | 3627000 | |||
| Cash and cash equivalents cash flow statement at end of period | 6976000 | |||
Statement of Asset and Liabilities |
|||
|---|---|---|---|
| Particulars | Year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-Apr-2024 | ||
| Date of end of reporting period | 31-Mar-2025 | ||
| Whether results are audited or unaudited | Audited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Equity and liabilities | |||
| 1 | Shareholders' funds | ||
| Share capital | 176686000 | ||
| Reserves and surplus | 135306000 | ||
| Money received against share warrants | 0 | ||
| Total shareholders' funds | 311992000 | ||
| 2 | Share application money pending allotment | 0 | |
| 3 | Deferred government grants | 0 | |
| 4 | Minority interest | 352000 | |
| 5 | Non-current liabilities | ||
| Long-term borrowings | 259614000 | ||
| Deferred tax liabilities (net) | |||
| Foreign currency monetary item translation difference liability account | |||
| Other long-term liabilities | |||
| Long-term provisions | 838000 | ||
| Total non-current liabilities | 260452000 | ||
| 6 | Current liabilities | ||
| Short-term borrowings | 275988000 | ||
| Trade Payables | |||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0 | ||
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 187983000 | ||
| Total Trade payable | 187983000 | ||
| Other current liabilities | 48220000 | ||
| Short-term provisions | 15562000 | ||
| Total current liabilities | 527753000 | ||
| Total equity and liabilities | 1100549000 | ||
| Assets | |||
| 1 | Non-current assets | ||
| i | Property, Plant and Equipment and Intangible assets | ||
| Property, Plant and Equipment | 9821000 | ||
| Producing properties | 0 | ||
| Intangible assets | 100000 | Preproducing properties | 0 |
| Property, Plant and Equipment capital work-in-progress | 180000 | ||
| Intangible assets under development or work-in-progress | 0 | ||
| Total Property, Plant and Equipment and Intangible assets | 10101000 | ||
| ii | Non-current investments | 0 | |
| v | Deferred tax assets (net) | 447000 | |
| vi | Foreign currency monetary item translation difference asset account | ||
| vii | Long-term loans and advances | 130000 | |
| viii | Other non-current assets | ||
| Total non-current assets | 10678000 | ||
| Current assets | |||
| Current investments | 0 | ||
| Inventories | 553861000 | ||
| Trade receivables | 418875000 | ||
| Cash and cash equivalents | 6976000 | ||
| Bank balance other than cash and cash equivalents | 0 | ||
| Short-term loans and advances | 101392000 | ||
| Other current assets | 8767000 | ||
| Total current assets | 1089871000 | ||
| Total assets | 1100549000 | ||
| Disclosure of notes on assets and liabilities | |||
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results |
|||||||
|---|---|---|---|---|---|---|---|
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
| Date of start of reporting period | 01-Oct-2024 | 01-Apr-2024 | |||||
| Date of end of reporting period | 31-Mar-2025 | 31-Mar-2025 | |||||
| Whether results are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | |||||||
| Net Segment Asset | |||||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | |||||||
| Net Segment Liabilities | |||||||
| Disclosure of notes on segments | |||||||
Details of Impact of Audit Qualification |
|
|---|---|
| Whether results are audited or unaudited | Audited |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | KUMBHAT & CO. LLP | Yes | 30-Sep-2026 | ||
|---|---|---|---|---|---|